Tag: pain management drugs market size

  • Global Pain Management Drugs Market Forecast 2024-2033: Estimated Market Size And Growth Rate

    Global Pain Management Drugs Market Forecast 2024-2033: Estimated Market Size And Growth Rate

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    How Much Growth is Expected for the Pain Management Drugs Market from 2024 to 2033?

    The market size for pain management drugs has seen robust growth in the past few years. The market, which is presently worth $76.76 billion in 2023, is anticipated to elevate to $81.08 billion by 2024, exhibiting a compound annual growth rate (CAGR) of 5.6%. The historic growth rate can be linked to an upswing in chronic pain instances, an escalation in cancer cases, an upward trend in surgical procedures, enhanced pain evaluations, and various governmental initiatives.

    The market size of pain management drugs is projected to witness significant growth in the coming years, reaching $100.94 billion in 2028 with a 5.6% compound annual growth rate (CAGR). This growth within the forecast period is believed to be driven by factors such as non-opioid alternatives, targeted therapies, precision medicine tactics, psychological methods, and an emphasis on reducing side effects. There are also major trends to watch out in this forecast period, including value-based care models, extensive access programs, combined treatments, innovative formulations, and pain drugs that are biosimilar.

    Claim Your Free Sample of the Global Pain Management Drugs Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9846&type=smp

    What Factors Are Encouraging Growth in the pain management drugs Market?

    The escalation in the frequency of surgical procedures is projected to accelerate the expansion of the pain management drugs market in the coming years. Surgical operations constitute medical practices that require physical intrusion into the body’s tissues to treat ailments, conditions or injuries, and modify body functions or enhance looks. Pain relief medications have a vital role within these procedures by enabling the management and relief of post-surgical pain, critically enhancing patient wellbeing and recuperation. For example, data from the Aesthetic Society illustrates that in 2021, surgical protocols observed a significant upsurge of 54% compared to 2020, while there was a 44% surge in non-invasive procedures. Thus, the growing frequency of surgeries is propelling the market for pain relief medications.

    Which Segments Play a Vital Role in the Pain Management Drugs Market?

    1) By Drug Class: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Anesthetics, Anticonvulsants, Anti-migraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics

    2) By Indication: Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia, Muscle sprain/strain, Bone fracture, Other Indications

    3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    What Trends Are Driving Change in the Pain Management Drugs Market?

    The pain management drugs market is increasingly being influenced by technological innovation. The central focus of multiple major firms within this market is the development of novel technologies. For instance, in November 2021, AppliedVR, Inc., a U.S. firm that provides virtual reality medical treatments, introduced EaseVRx, an immersive virtual reality (VR) system available only through prescription, which targets patients over 18 years old with chronic lower back pain. The system aims to lessen pain through cognitive behavioural therapy and other behavioural techniques. What sets EaseVRx apart is its application of CBT and other behavioural intervention methods for pain and pain interference reduction. The EaseVRx therapy plan comprises 56 VR sessions varying in duration from 2 to 16 minutes and is meant to be employed daily over an eight-week treatment period. The VR software of the equipment employs a treatment programme based on skills, which uses firm principles of behavioural therapy to reduce the physiological symptoms associated with pain.

    Order Now for Fast Delivery of Your Pain Management Drugs Market Report!

    https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

    What Regions Are Contributing Significantly to the Growth of the Pain Management Drugs Market?

    North America was the largest region in the pain management drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the pain management drug market report during the forecast period. The regions covered in the pain management drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Pain Management Drugs Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the pain management drugs market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Pain Management Drugs Market Include

    1. Pain Management Drugs Market Executive Summary

    2. Pain Management Drugs Market Segments

    3. Pain Management Drugs Market Size And Template Market Growth Rate

    4. Key Pain Management Drugs Market Trends

    5. Major Pain Management Drugs Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Pain Management Drugs Market

    26. Top Pain Management Drugs Companies

    27. Pain Management Drugs Market Opportunities And Strategies

    28. Pain Management Drugs Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Top 5 Insights From The Pain Management Drugs Market Report 2024

    Top 5 Insights From The Pain Management Drugs Market Report 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Pain Management Drugs Global Market Report 2024, the pain management drugs market is expected to show promising growth in the forecast period.

    The pain management drugs market has witnessed substantial growth in recent years, driven by various factors and trends.

    • Market size increased from $76.76 billion in 2023 to $81.08 billion in 2024, boasting a Compound Annual Growth Rate (CAGR) of 5.6%.
    • Historic growth attributed to rising chronic pain cases, increased cancer incidences, higher surgical procedures, improved pain assessment techniques, and governmental initiatives.

    Anticipated Growth Trajectory

    Expectations for the pain management drugs market suggest continued expansion in the forthcoming years.

    • Foreseen growth to $100.94 billion in 2028, with a CAGR of 5.6%.
    • Forecasted drivers include non-opioid alternatives, targeted therapies, precision medicine, psychological interventions, and efforts to minimize side effects.

    Surge In Surgeries Driving Market Growth

    The escalating rate of surgical procedures serves as a significant catalyst for the growth of the pain management drugs market.

    • Surgical interventions involve tissue penetration or alteration to treat diseases, injuries, or enhance bodily functions.
    • Pain management drugs play a pivotal role in post-operative pain control, enhancing patient comfort and recovery.
    • Surgeons and patients increasingly rely on pain management drugs for optimal surgical outcomes, as evidenced by a notable increase in surgical procedures.

    Key Players Shaping the Market

    A multitude of companies contribute to the dynamic landscape of the pain management drugs market.

    • Novartis AG
    • Eli Lilly And Company
    • Abbott Laboratories
    • Endo International PLC
    • Purdue Pharma L.P.
    • Pfizer Inc.
    • Merck & Co. Inc.
    • Johnson & Johnson Services Inc.
    • GlaxoSmithKline PLC
    • AbbVie Inc.
    • Bristol-Myers Squibb Company
    • Teva Pharmaceutical Industries Ltd.
    • AstraZeneca PLC
    • Mylan N.V.
    • Bausch Health Companies Inc.
    • Becton Dickinson and Company
    • Boston Scientific Corporation
    • Baxter International Inc.
    • Sanofi
    • Medtronic PLC
    • Hoffmann-La Roche Ltd.
    • Torrent Pharmaceuticals Ltd.

    View More On The Pain Management Drugs Market Report 2024 – https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

    Technological Advancement Reshaping Treatment

    Technological innovation stands as a prominent trend reshaping the pain management drugs market.

    • Companies focus on pioneering new technologies to enhance treatment efficacy.
    • AppliedVR, Inc.’s EaseVRx, a prescription-only immersive virtual reality system, offers innovative pain management for chronic lower back pain through cognitive behavioral therapy.
    • Technological advancements like VR therapy redefine pain management paradigms, providing patients with novel alternatives for pain relief.

    Strategic Acquisitions Strengthen Market Position

    Strategic acquisitions play a vital role in fortifying companies’ positions in the pain management drugs market.

    • Pacira BioSciences’ acquisition of Flexion Therapeutics enriches its non-opioid pain management portfolio.
    • The acquisition expands Pacira’s product offerings, incorporating Flexion’s ZILRETTA for osteoarthritis knee pain treatment.
    • Pacira solidifies its commitment to non-opioid solutions, underscoring the growing importance of alternative pain management approaches.

    Market Segmentation Insights

    Understanding the nuanced segments of the pain management drugs market is essential for comprehensive market analysis.

    1. By Drug Class: NSAIDs, Anesthetics, Anticonvulsants, Anti-migraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics
    2. By Indication: Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia, Muscle sprain/strain, Bone fracture, Other Indications
    3. By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    Regional Insights

    North America leads the pain management drugs market in 2023, while Asia-Pacific is projected as the fastest-growing region during the forecast period.

    In conclusion, the pain management drugs market continues to evolve, driven by technological advancements, strategic acquisitions, and shifting treatment paradigms. As stakeholders embrace innovation and explore alternative therapies, the market is poised for sustained growth and transformation in the years ahead.

    Request A Sample Of The Global Pain Management Drugs Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=9846&type=smp